Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > HLVX HilleVax > Detailed Quotes

HLVX HilleVax

Watchlist
12.480
-1.560-11.11%
Trading Session 06/27 10:45 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
14.730
Open
14.730
Turnover
1.07M
Low
12.340
Pre Close
14.040
Volume
78.46K
Market Cap
417.17M
P/E(TTM)
Loss
52wk High
20.950
Shares
33.43M
P/E(Static)
Loss
52wk Low
7.900
Float Cap
168.85M
Bid/Ask %
-33.33%
Historical High
20.950
Shs Float
13.53M
Volume Ratio
0.63
Historical Low
7.900
Dividend TTM
--
Div Yield TTM
--
P/B
-2.48
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.58%
Amplitude
17.02%
Avg Price
13.639
Lot Size
1
Float Cap
168.85M
Bid/Ask %
-33.33%
Historical High
20.950
Shs Float
13.53M
Volume Ratio
0.63
Historical Low
7.900
Dividend TTM
--
P/B
-2.48
Dividend LFY
--
Turnover Ratio
0.58%
Amplitude
17.02%
Avg Price
13.639
Lot Size
1
Price Forecast

No Data

News

Comment

No Data

Company Overview More
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
CEO: Hershberg M.D., Ph.D., Robert M.
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top